Henoch-Schonlein purpura in children Limited benefit of corticosteroids

被引:0
作者
Bluman, Joel [1 ]
Goldman, Ran D. [1 ]
机构
[1] British Columbia Childrens Hosp, Dept Pediat, Vancouver, BC V6H 3V4, Canada
关键词
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PREDNISONE; MANIFESTATIONS; NEPHROPATHY; MANAGEMENT; CHILDHOOD; DIAGNOSIS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Question A child recently presented to my office with lower limb petechiae, arthralgia, and abdominal pain characteristic of Henoch-Schonlein purpura (HSP). Will systemic corticosteroids help relieve these symptoms and prevent potential HSP complications such as intussusception and nephritis? Answer Henoch-Schonlein purpura is a common and self-limiting disease in children. Current evidence does not support universal treatment of HSP with corticosteroids. Recent trials and meta-analyses found that corticosteroids do not prevent the onset of renal disease or abdominal complications. However, corticosteroids are effective as treatment of abdominal pain, arthralgia, and purpura. Clinicians are advised to use their discretion in choosing which patients might benefit most from oral corticosteroid treatment.
引用
收藏
页码:1006 / 1008
页数:3
相关论文
共 19 条
[1]   Gastrointestinal manifestations in Henoch-Schonlein purpura: a review of 261 patients [J].
Chang, WL ;
Yang, YH ;
Lin, YT ;
Chiang, BL .
ACTA PAEDIATRICA, 2004, 93 (11) :1427-1431
[2]   Interventions for preventing and treating kidney disease in Henoch-Schonlein Purpura (HSP) (Review) [J].
Chartapisak, Wattana ;
Opastirakul, Sauwalak ;
Hodson, Elisabeth M. ;
Willis, Narelle S. ;
Craig, Jonathan C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03)
[3]   Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP) [J].
Dudley, Jan ;
Smith, Graham ;
Llewelyn-Edwards, Anne ;
Bayliss, Kate ;
Pike, Katie ;
Tizard, Jane .
ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (10) :756-763
[4]  
Duvuru G, 2013, RHEUMATOLOGY
[5]   Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins [J].
Gardner-Medwin, JMM ;
Dolezalova, P ;
Cummins, C ;
Southwood, TR .
LANCET, 2002, 360 (9341) :1197-1202
[6]   A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383] [J].
Huber, Adam M. ;
King, Jim ;
McLaine, Peter ;
Klassen, Terry ;
Pothos, Mary .
BMC MEDICINE, 2004, 2 (1)
[7]   Outcome of Henoch-Schonlein purpura 8 years after treatment with a placebo or prednisone at disease onset [J].
Jauhola, Outi ;
Ronkainen, Jaana ;
Koskimies, Olli ;
Ala-Houhala, Marja ;
Arikoski, Pekka ;
Holtta, Tuula ;
Jahnukainen, Timo ;
Rajantie, Jukka ;
Ormala, Timo ;
Nuutinen, Matti .
PEDIATRIC NEPHROLOGY, 2012, 27 (06) :933-939
[8]   Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children [J].
Jauhola, Outi ;
Ronkainen, Jaana ;
Koskimies, Olli ;
Ala-Houhala, Marja ;
Arikoski, Pekka ;
Holtta, Tuula ;
Jahnukainen, Timo ;
Rajantie, Jukka ;
Ormala, Timo ;
Turtinen, Juha ;
Nuutinen, Matti .
ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (11) :877-882
[9]   Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study [J].
Jauhola, Outi ;
Ronkainen, Jaana ;
Koskimies, Olli ;
Ala-Houhala, Marja ;
Arikoski, Pekka ;
Holtta, Tuula ;
Jahnukainen, Timo ;
Rajantie, Jukka ;
Ormala, Timo ;
Nuutinen, Matti .
ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (11) :871-876
[10]   EFFECTIVENESS OF EARLY PREDNISONE TREATMENT IN PREVENTING THE DEVELOPMENT OF NEPHROPATHY IN ANAPHYLACTOID PURPURA [J].
MOLLICA, F ;
LIVOLTI, S ;
GAROZZO, R ;
RUSSO, G .
EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (02) :140-144